首页 | 本学科首页   官方微博 | 高级检索  
检索        

ELF静脉化疗与HCPT腹腔化疗对晚期胃癌的疗效评价
引用本文:黄卫兵,朱敏.ELF静脉化疗与HCPT腹腔化疗对晚期胃癌的疗效评价[J].齐齐哈尔医学院学报,2005,26(4):367-367,369.
作者姓名:黄卫兵  朱敏
作者单位:江苏省镇江第一人民医院肿瘤科,212002;江苏省镇江第一人民医院肿瘤科,212002
摘    要:目的观察并评价静脉与腹腔化疗治疗晚期胃癌的近期疗效及毒副反应。方法ELF(CF、5-Fu、VP16)静滴加羟基喜树碱(HCPT)腹腔化疗35例晚期胃癌.记录近期疗效及毒副反应。结果35例总有效率57.1%,其中CR8.6%,毒副反应较轻,主要为骨髓抑制、消化道反应。结论静脉化疗加腹腔化疗治疗晚期胃癌疗效肯定.毒副反应较轻,值得推广。

关 键 词:晚期胃癌  腹腔化疗  静脉化疗

Evaluation of Intravenous Chemotherapy of ELF and Intraperitoneal Chemotherapy of HCPT in Advanced Gastric Cancer
Huang Weibing et al..Evaluation of Intravenous Chemotherapy of ELF and Intraperitoneal Chemotherapy of HCPT in Advanced Gastric Cancer[J].Journal of Qiqihar Medical College,2005,26(4):367-367,369.
Authors:Huang Weibing
Institution:Tumor Department Zhenjiang First Hospital Jiangsu 212002 China
Abstract:Objective To evaluate the therapeutic effects and toxicities of intraperitoneal versus intravenous chemotherapy in advanced gastric cancer.Methods 35 cases of patients were treated with ELF intravenous chemotherapy of leucovorin (CF),fluorouracil(5-Fu),etoposide(VP16) and intraperitoneal chemotherapy of hydroxycamptothecin(HCPT) in advanced gastric cancer.The therapeutic effect and toxicities were observed.Results Overall responsive rate was 57.1%,among them,CR was 8.6%,myelosuppression,alimentary tract reaction were main toxicities,caused by chemotherapy.Conclusions There are obvious clinical efficacies and less adverse effects in the treatment of patients with advanced gastric cancer while intravenous chemotherapy of ELF and intraperitoneal chemotherapy of HCPT are administered,Further study should be carried out.
Keywords:Advanced gastric cancer Intraperitoneal chemotherapy Intravenous chemotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号